Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

LKN MEDICAL : revenue, balance sheet and financial ratios

LKN MEDICAL is a French company founded 15 years ago, specialized in the sector Autres intermédiaires du commerce en produits divers. Based in MONTBRISON (42600), this company of category PME shows in 2023 a revenue of 2.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LKN MEDICAL (SIREN 522996156)
Indicator 2025 2024 2023 2022 2021 2020
Revenue N/C N/C 2 139 949 € N/C N/C N/C
Net income 444 705 € 295 027 € 172 651 € 361 678 € 197 906 € 77 284 €
EBITDA N/C N/C 326 064 € N/C N/C N/C
Net margin N/C N/C 8.1% N/C N/C N/C

Revenue and income statement

In 2025, LKN MEDICAL generates positive net income of 445 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 77 k€ -> 445 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

444 705 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.288%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

78.274%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.2%

Solvency indicators evolution
LKN MEDICAL

Sector positioning

Debt ratio
1.29 2025
2023
2024
2025
Q1: 0.0
Med: 4.8
Q3: 30.28
Good -20 pts over 3 years

In 2025, the debt ratio of LKN MEDICAL (1.29) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
78.27% 2025
2023
2024
2025
Q1: 10.66%
Med: 43.97%
Q3: 70.72%
Excellent +6 pts over 3 years

In 2025, the financial autonomy of LKN MEDICAL (78.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.44 years 2023
2023
Q1: 0.0 years
Med: 0.0 years
Q3: 0.93 years
Average

In 2023, the repayment capacity of LKN MEDICAL (0.44) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 421.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

421.693

Liquidity indicators evolution
LKN MEDICAL

Sector positioning

Liquidity ratio
421.69 2025
2023
2024
2025
Q1: 148.43
Med: 278.51
Q3: 620.74
Good +5 pts over 3 years

In 2025, the liquidity ratio of LKN MEDICAL (421.69) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
5.33x 2023
2023
Q1: 0.0x
Med: 0.0x
Q3: 1.28x
Excellent

In 2023, the interest coverage of LKN MEDICAL (5.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LKN MEDICAL

Positioning of LKN MEDICAL in its sector

Comparison with sector Autres intermédiaires du commerce en produits divers

Valuation estimate

Based on 85 transactions of similar company sales (all years), the value of LKN MEDICAL is estimated at 610 605 € (range 291 151€ - 3 130 687€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
85 tx
291k€ 610k€ 3130k€
610 605 € Range: 291 151€ - 3 130 687€
NAF 5 all-time

Valuation method used

Net Income Multiple
444 705 € × 1.4x = 610 606 €
Range: 291 151€ - 3 130 688€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 85 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres intermédiaires du commerce en produits divers)

Compare LKN MEDICAL with other companies in the same sector:

Frequently asked questions about LKN MEDICAL

What is the revenue of LKN MEDICAL ?

The revenue of LKN MEDICAL in 2023 is 2.1 M€.

Is LKN MEDICAL profitable?

Yes, LKN MEDICAL generated a net profit of 445 k€ in 2025.

Where is the headquarters of LKN MEDICAL ?

The headquarters of LKN MEDICAL is located in MONTBRISON (42600), in the department Loire.

Where to find the tax return of LKN MEDICAL ?

The tax return of LKN MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LKN MEDICAL operate?

LKN MEDICAL operates in the sector Autres intermédiaires du commerce en produits divers (NAF code 46.19B). See the 'Sector positioning' section above to compare the company with its competitors.